|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
|
US7464706B2
(en)
|
1999-07-23 |
2008-12-16 |
Mannkind Corporation |
Unit dose cartridge and dry powder inhaler
|
|
US7305986B1
(en)
|
1999-07-23 |
2007-12-11 |
Mannkind Corporation |
Unit dose capsules for use in a dry powder inhaler
|
|
GB0201677D0
(en)
*
|
2002-01-25 |
2002-03-13 |
Glaxo Group Ltd |
Medicament dispenser
|
|
AU2003220125B2
(en)
|
2002-03-20 |
2006-06-15 |
Mannkind Corporation |
Inhalation apparatus
|
|
PL1786784T3
(pl)
|
2004-08-20 |
2011-04-29 |
Mannkind Corp |
Kataliza syntezy diketopiperazyn
|
|
EP2314298B1
(en)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Microparticles comprising diketopiperazine salts for drug delivery
|
|
US8763605B2
(en)
|
2005-07-20 |
2014-07-01 |
Manta Devices, Llc |
Inhalation device
|
|
AU2006290870B2
(en)
|
2005-09-14 |
2013-02-28 |
Mannkind Corporation |
Method of drug formulation based on increasing the affinity of active agents for crystalline microparticle surfaces
|
|
USD613848S1
(en)
|
2006-02-16 |
2010-04-13 |
Glaxo Group Limited |
Inhalation device
|
|
DK1986679T3
(da)
|
2006-02-22 |
2017-11-20 |
Mannkind Corp |
Fremgangsmåde til forbedring af mikropartiklers farmaceutiske egenskaber omfattende diketopiperazin og et aktivt indholdsstof
|
|
EP2011536A1
(en)
*
|
2007-07-06 |
2009-01-07 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Inhaler
|
|
EP3453418A1
(en)
*
|
2007-07-06 |
2019-03-13 |
Manta Devices, LLC |
Delivery device and related methods
|
|
US11224704B2
(en)
|
2007-07-06 |
2022-01-18 |
Manta Devices, Llc |
Dose delivery device for inhalation
|
|
GB0719299D0
(en)
|
2007-10-03 |
2007-11-14 |
Optinose As |
Nasal delivery devices
|
|
WO2009079078A1
(en)
|
2007-12-14 |
2009-06-25 |
Labogroup S.A.S. |
Delivering aerosolizable food products
|
|
AU2009228074B2
(en)
*
|
2008-03-27 |
2015-01-22 |
Mannkind Corporation |
A dry powder inhalation system
|
|
AU2015201158B2
(en)
*
|
2008-03-27 |
2017-04-13 |
Mannkind Corporation |
A dry powder inhalation system
|
|
WO2009128491A1
(ja)
*
|
2008-04-17 |
2009-10-22 |
帝人ファーマ株式会社 |
定量噴霧式吸入器用吸入補助器具
|
|
CN103252007B
(zh)
|
2008-06-13 |
2016-06-22 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
|
JP5479465B2
(ja)
*
|
2008-06-20 |
2014-04-23 |
マンカインド コーポレイション |
吸入努力をリアルタイムにプロファイルする対話式機器および方法
|
|
US20100032444A1
(en)
*
|
2008-08-07 |
2010-02-11 |
Wanda Sheffield |
Dispenser For An Orally Dissolvable Strip
|
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
|
NZ574666A
(en)
*
|
2009-02-05 |
2009-04-30 |
Nexus6 Ltd |
A medicament inhaler holder that uses optical means to count and display the number of doses used
|
|
ES2739352T3
(es)
|
2009-02-26 |
2020-01-30 |
Glaxo Group Ltd |
Formulaciones farmacéuticas que comprenden 4-{(1R)-2-[(6-{2-[(2,6-diclorobencil)oxi]etoxi}hexil)amino]-1-hidroxietil}-2-(hidroximetil)fenol
|
|
EP2676695A3
(en)
|
2009-03-11 |
2017-03-01 |
MannKind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
|
EP2432533B1
(en)
|
2009-05-18 |
2015-07-01 |
Norton Healthcare Limited |
Dry-powder inhaler
|
|
EA021160B1
(ru)
|
2009-05-18 |
2015-04-30 |
Нортон Хэлткэа Лимитед |
Сухопорошковый ингалятор
|
|
PL2432530T3
(pl)
*
|
2009-05-18 |
2015-04-30 |
Norton Healthcare Ltd |
Inhalator do suchego proszku
|
|
GB0910537D0
(en)
*
|
2009-06-18 |
2009-07-29 |
Ivax Pharmaceuticals Ireland |
Inhaler
|
|
KR101875969B1
(ko)
|
2009-06-12 |
2018-07-06 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
|
TR201002877A2
(tr)
*
|
2010-04-13 |
2011-10-21 |
Bi̇lgi̇ç Mahmut |
Blister ambalaj içeren inhalasyon cihazı
|
|
WO2011129788A1
(en)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
User-friendly dry powder inhaler
|
|
US9345848B2
(en)
|
2009-10-20 |
2016-05-24 |
Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. |
Dry powder inhaler
|
|
WO2011129790A1
(en)
*
|
2010-04-13 |
2011-10-20 |
Mahmut Bilgic |
Inhaler which creates turbulance
|
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
|
KR20120115264A
(ko)
*
|
2009-11-13 |
2012-10-17 |
머크 샤프 앤드 돔 코포레이션 |
다수의 저장부를 가지는 투약 제품 및 건식 분말 흡입기
|
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
|
EA027141B1
(ru)
*
|
2010-04-13 |
2017-06-30 |
Сима Патент Ве Лисанслама Хизметлери Лтд. Сти. |
Кнопочное устройство мундштука ингалятора сухого порошка
|
|
EP2566551B1
(en)
*
|
2010-04-13 |
2016-03-30 |
Sima Patent ve Lisanslama Hizmetleri Ltd.Sti. |
Inhalation device
|
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
|
ES2705494T3
(es)
|
2010-08-31 |
2019-03-25 |
Glaxosmithkline Ip Dev Ltd |
Productos farmacológicos para la inhalación de polvo seco que presentan propiedades de control de la humedad y procedimientos de administración de los mismos
|
|
EP2611423B2
(en)
|
2010-08-31 |
2022-09-21 |
GlaxoSmithKline Intellectual Property Development Limited |
Dry powder inhalation drug products exhibiting moisture control properties and methods of administering the same
|
|
CN105667994B
(zh)
|
2011-04-01 |
2018-04-06 |
曼金德公司 |
用于药物药盒的泡罩包装
|
|
CA2838030A1
(en)
|
2011-06-08 |
2012-12-13 |
Glaxo Group Limited |
Combination comprising umeclidinium and a corticosteroid
|
|
RU2013153202A
(ru)
|
2011-06-08 |
2015-07-20 |
Глаксо Груп Лимитед |
Композиции для ингалятора сухого порошка, содержащие умеклидиний
|
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
|
WO2013063160A1
(en)
|
2011-10-24 |
2013-05-02 |
Mannkind Corporation |
Methods and compositions for treating pain
|
|
US9849255B2
(en)
|
2011-11-25 |
2017-12-26 |
Mahmut Bilgic |
Inhalation device
|
|
ES2814336T3
(es)
|
2012-04-13 |
2021-03-26 |
Glaxosmithkline Ip Dev Ltd |
Partículas de agregado
|
|
US8989896B2
(en)
*
|
2012-04-24 |
2015-03-24 |
Arthur E. Brown |
High efficiency automated pharmaceutical dispenser
|
|
EP2662105B1
(de)
|
2012-05-09 |
2017-01-18 |
Boehringer Ingelheim International GmbH |
Zerstäuber
|
|
US20150096563A1
(en)
*
|
2012-05-25 |
2015-04-09 |
Arven Ilac Sanayi Ve Ticaret A.S. |
Inhaler comprising a inner body having an air channel
|
|
US9631511B2
(en)
*
|
2012-06-27 |
2017-04-25 |
Ecoservices, Llc |
Engine wash apparatus and method
|
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
|
GB201222679D0
(en)
|
2012-12-17 |
2013-01-30 |
Glaxo Group Ltd |
Pharmaceutical combination products
|
|
EP2970149B1
(en)
|
2013-03-15 |
2019-08-21 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions and methods
|
|
AU353859S
(en)
|
2013-04-11 |
2014-02-25 |
Glaxo Group Ltd |
Inhaler
|
|
CN105451716A
(zh)
|
2013-07-18 |
2016-03-30 |
曼金德公司 |
热稳定性干粉药物组合物和方法
|
|
WO2015021064A1
(en)
|
2013-08-05 |
2015-02-12 |
Mannkind Corporation |
Insufflation apparatus and methods
|
|
USD744087S1
(en)
|
2013-10-01 |
2015-11-24 |
Mahmut Bilgic |
Dry powder inhaler
|
|
US10307464B2
(en)
|
2014-03-28 |
2019-06-04 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
|
WO2015168572A2
(en)
|
2014-05-02 |
2015-11-05 |
Manta Devices, Llc |
Delivery device and related methods
|
|
JP6291342B2
(ja)
*
|
2014-05-13 |
2018-03-14 |
アークレイ株式会社 |
測定装置及び測定装置の動作方法
|
|
US10987363B2
(en)
|
2014-05-28 |
2021-04-27 |
Glaxosmithkline Intellectual Property Development Limited |
Fluticasone furoate in the treatment of COPD
|
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
|
US11116918B2
(en)
*
|
2015-03-02 |
2021-09-14 |
Abithas, Inc. |
Delivery system for metered dose inhalers
|
|
GB201503720D0
(en)
|
2015-03-05 |
2015-04-22 |
Glaxosmithkline Ip No 2 Ltd |
Chemical compound
|
|
AU2016231122A1
(en)
|
2015-03-11 |
2017-09-07 |
Glaxosmithkline Intellectual Property Development Limited |
TSLP binding proteins
|
|
GB201504689D0
(en)
|
2015-03-19 |
2015-05-06 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
US9500435B2
(en)
*
|
2015-04-21 |
2016-11-22 |
Jui-Fu Tseng |
Spherical particle dispenser
|
|
CN107709306A
(zh)
|
2015-06-15 |
2018-02-16 |
葛兰素史密斯克莱知识产权发展有限公司 |
Nrf2调节剂
|
|
PT3307739T
(pt)
|
2015-06-15 |
2021-01-04 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de nrf2
|
|
ES2910938T3
(es)
|
2015-06-15 |
2022-05-17 |
Glaxosmithkline Ip Dev Ltd |
Reguladores de NRF2
|
|
USD861852S1
(en)
*
|
2015-08-13 |
2019-10-01 |
Adherium (Nz) Limited |
Compliance monitor for a medicament inhaler
|
|
UY36851A
(es)
|
2015-08-16 |
2017-03-31 |
Glaxosmithkline Ip Dev Ltd |
Compuestos para uso en aplicaciones antibacterianas
|
|
KR20150112912A
(ko)
*
|
2015-09-17 |
2015-10-07 |
최성숙 |
바이오센서 스트립의 저장장치 및 이를 포함하는 혈당측정기
|
|
JP2018529744A
(ja)
|
2015-10-06 |
2018-10-11 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２レギュレーターとしてのアリールシクロヘキシルピラゾール
|
|
US10364256B2
(en)
|
2015-10-06 |
2019-07-30 |
Glaxosmithkline Intellectual Property Development Limited |
Biaryl pyrazoles as NRF2 regulators
|
|
JP2019516485A
(ja)
|
2016-05-19 |
2019-06-20 |
マンカインド コーポレイション |
吸入を検出および監視するための機器、システム、および方法
|
|
EP3472566A1
(en)
|
2016-06-17 |
2019-04-24 |
Thin Film Electronics ASA |
Wireless mechanism for detecting an open or closed container, and methods of making and using the same
|
|
GB201614934D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614940D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Intellectual Property (No 2) Ltd |
Chemical compounds
|
|
GB201614939D0
(en)
|
2016-09-02 |
2016-10-19 |
Glaxosmithkline Ip Dev Ltd |
Crystalline hydrate
|
|
JP7106528B2
(ja)
|
2016-09-20 |
2022-07-26 |
グラクソスミスクライン、インテレクチュアル、プロパティー、（ナンバー２）、リミテッド |
Ｔｒｐｖ４拮抗薬
|
|
TW201825458A
(zh)
|
2016-09-20 |
2018-07-16 |
英商葛蘭素史克智慧財產（第二）有限公司 |
Ｔｒｐｖ４拮抗劑
|
|
US10590077B2
(en)
|
2016-09-20 |
2020-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
TRPV4 antagonists
|
|
USD818112S1
(en)
*
|
2016-10-19 |
2018-05-15 |
Reciprocal Labs Corporation |
Usage monitoring attachment for a dry powder inhaler
|
|
KR20190088404A
(ko)
|
2016-12-06 |
2019-07-26 |
글락소스미스클라인 인털렉츄얼 프로퍼티 디벨로프먼트 리미티드 |
3-(2,3-디히드로-1h-인덴-5-일)프로판산 유도체 및 nrf2 조절제로서의 그의 용도
|
|
US10426698B2
(en)
*
|
2016-12-08 |
2019-10-01 |
Breeden Brothers, LLC |
Pill container with cap
|
|
EP3551621A1
(en)
|
2016-12-12 |
2019-10-16 |
GlaxoSmithKline Intellectual Property Development Limited |
N-aryl pyrazoles as nrf2 regulators
|
|
JP2020500919A
(ja)
|
2016-12-12 |
2020-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２レギュレーターとしての３−カルボン酸ピロール
|
|
WO2018109647A1
(en)
|
2016-12-14 |
2018-06-21 |
Glaxosmithkline Intellectual Property Development Limited |
Bisaryl amides as nrf2 regulators
|
|
ES2848699T3
(es)
|
2016-12-14 |
2021-08-11 |
Glaxosmithkline Ip Dev Ltd |
Compuestos de 3-oxo-1,4-diazepinilo como activadores de NRF2
|
|
JP2020502123A
(ja)
|
2016-12-14 |
2020-01-23 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ |
Ｎｒｆ２アクチベーターとしてのビスアリール複素環
|
|
JP7110197B2
(ja)
|
2016-12-15 |
2022-08-01 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
Ｎｒｆ２アクチベーター
|
|
ES2908941T3
(es)
|
2016-12-15 |
2022-05-04 |
Glaxosmithkline Ip Dev Ltd |
Triazoles unidos a éter como reguladores de NRF2
|
|
CN108622469B
(zh)
*
|
2017-03-24 |
2023-08-15 |
李和伟 |
一种独立包装的履带式给药器
|
|
CN110662557A
(zh)
|
2017-03-31 |
2020-01-07 |
葛兰素史克知识产权开发有限公司 |
免疫原性组合物、用途和治疗方法
|
|
US12279921B2
(en)
|
2017-06-30 |
2025-04-22 |
Fresh Health Inc. |
Cleaning device for teeth
|
|
WO2020214697A1
(en)
|
2019-04-15 |
2020-10-22 |
Fresh Health Inc. |
Systems and methods for personalized oral care
|
|
US11281816B2
(en)
*
|
2020-07-21 |
2022-03-22 |
Fresh Health Inc. |
Systems and methods for manufacturing personalized oral care devices
|
|
EP3888467A1
(de)
*
|
2017-07-03 |
2021-10-06 |
Weber Maschinenbau GmbH Breidenbach |
Bereitstellen von bahnförmigem zwischenblattmaterial an einem schneidbereich
|
|
JP1600828S
(enExample)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
JP1600829S
(enExample)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
JP1600827S
(enExample)
*
|
2017-08-24 |
2018-04-02 |
|
|
|
US20190076607A1
(en)
*
|
2017-09-13 |
2019-03-14 |
Lupin Atlantis Holdings Sa |
Inhaler and mesh for an inhaler
|
|
WO2019116231A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
WO2019116230A1
(en)
|
2017-12-11 |
2019-06-20 |
Glaxosmithkline Intellectual Property Development Limited |
Nrf2 activator for the treatment of acute lung injury, acute respiratory distress syndrome and multiple organ dysfunction syndrome
|
|
GB201720989D0
(en)
|
2017-12-15 |
2018-01-31 |
Glaxosmithkline Ip Dev Ltd |
Chemical compounds
|
|
BR112020014431A2
(pt)
|
2018-01-17 |
2020-12-01 |
Glaxosmithkline Intellectual Property Development Limited |
inibidores de pl4kiiibeta
|
|
WO2019224667A1
(en)
|
2018-05-23 |
2019-11-28 |
Glaxosmithkline Intellectual Property Development Limited |
Indanes as nrf2 activators
|
|
GB201812671D0
(en)
|
2018-08-03 |
2018-09-19 |
Coalesce Product Dev Ltd |
An inhaler device
|
|
WO2020212678A1
(en)
*
|
2018-09-03 |
2020-10-22 |
Ttp Plc |
Medicament delivery device
|
|
WO2020058206A1
(en)
*
|
2018-09-17 |
2020-03-26 |
Vectura Delivery Devices Limited |
Dry powder inhaler
|
|
GB201908536D0
(en)
|
2019-06-13 |
2019-07-31 |
Glaxosmithkline Ip Dev Ltd |
Compounds
|
|
EP4487892A3
(en)
|
2020-06-15 |
2025-01-29 |
Norton (Waterford) Limited |
Blister pack and inhaler comprising the same
|
|
PL244222B1
(pl)
*
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
PL244221B1
(pl)
*
|
2020-09-24 |
2023-12-18 |
Polfarmex Spolka Akcyjna |
Inhalator do podawania leku
|
|
WO2022175425A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Intellectual Property Development Limited |
Inhaled mtor kinase inhibitors for use in the treatment or the prevention of a respiratory rna virus infection
|
|
WO2022175423A1
(en)
|
2021-02-22 |
2022-08-25 |
Glaxosmithkline Biologicals Sa |
Immunogenic composition, use and methods
|
|
WO2022179967A1
(en)
|
2021-02-23 |
2022-09-01 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Vadadustat for treating covid-19 in a hospitalized subject
|
|
GB202113921D0
(en)
|
2021-09-29 |
2021-11-10 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
EP4221792B1
(en)
|
2021-09-29 |
2025-05-14 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
|
WO2023052477A1
(en)
|
2021-09-29 |
2023-04-06 |
Norton (Waterford) Limited |
Dry powder medicament inhaler
|
|
ES3030527T3
(en)
|
2021-09-29 |
2025-06-30 |
Norton Waterford Ltd |
Dry powder medicament inhaler
|
|
WO2023110825A2
(en)
*
|
2021-12-17 |
2023-06-22 |
Sandoz Ag |
Inhaler device
|
|
GB2618145A
(en)
*
|
2022-04-29 |
2023-11-01 |
Merxin Ltd |
Manifold
|
|
WO2024167763A2
(en)
*
|
2023-02-06 |
2024-08-15 |
Transpire Bio Inc. |
Dual strip dry powder inhaler and manifolds for use therein
|
|
WO2025149765A1
(en)
*
|
2024-01-10 |
2025-07-17 |
Emphasys Importadora Exportadora E Distribuidora Ltda. |
Dry powder inhaler
|